ANNUAL REPORT 2025-2026

H SER=tL DRUGS LIMITED Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INOORE-452016 (M.P.) INDIA Tel. : (0731) 2517677 I E-mail : beryldrugS-45@yahoo.comICIN : L02423MP1993PLC007840 Oate: 03.09.2026 DCS-Listing The Bombay Stock Exchange limited, Phiroze JeeJeebhoy Towers. Dalal Street, Mumbai-400001 Sub: Sub: Annual Report for the Financial Year 2025-26 convening the 33'd Annual General Meeting 35 required under Regulation 34 (I) of the SEBI llisting Obligations and Disclosure Requirements) Regulations, 2015. Sir/ Madam, P~r.suant to Regulation 34{1) of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Annual Report of the Company for the Financial Year 2025-2026 convening the 33r<1 Annual General Meeting to be held on Tuesday, 29 September, 2026 at 11:00 AM at Kanchan Palace, Community Hall, Nipania Ring Road Indore (M.P.). We are pleased to submit the 33'd Annual Report for the year 2025-2026 of the Company containing the Balance Sheet as at 31" March, 2026 and the Statement of the Profit and lOSS and Cash Flow for the year ended 31st March, 2026 and the Board's Report along with Corporate Governance Report and the Auditor's Report on that date and its annexure, being sent to the Members of the Company by email! physical copy, as may be required. Kindly take this information on record and acknowledge the same. This is for your Information and records. Thanking You, Yours Sincerely, For Beryl Drugs Um~i ~<;=;~ \. _7. ) .,:. ' ," r -. -.. )..~ -l . SudhirSethi ,'" (\"i'~~:o, ',0 .' .... ) Chairman& Dire:ctor - __ OIN 00090172 33 ANNUAL REPORT 2025-2026 33rd Annual Report THIRTY-THIRD ANNUAL REPORT 2025-2026 CORPORATE INFORMATION BERYL DRUGS LTD. CIN: L02423MP1993PLC007840 ANNUAL GENERAL MEETING BOARD OF DIRECTORS Date : 29th September, 2026 Mr. Sanjay Sethi - Managing Director Day : Tuesday Mr. Sudhir Sethi - Chairman and Director Time : 11:00 A.M Mr. Shailendra Pathak- Whole Time Director Mr. Abhinav Naik- Independent Director Place : Kanchan Palace, Community Hall, Mrs. Shreya Saraf- Women Independent Director Nipania, Ring Road, Indore (M.P) Mrs. Neha Sarda- Women Independent Director REGISTERED OFFICE KEY MANAGERIAL PERSONNEL 29, Neer Nagar, Mayank Water Park Road, Mr. Sanjay Sethi : Managing Director Bicholi, Indore - 452016 (M.P.) Mr. Sudhir Sethi : Chairman & Director Mr. Ashish Baraskar : Chief Financial Officer (Old Address: 133, Kanchan Bagh Mr. Kamlesh Gupta : Company Secretary & Indore- 452001 (M.P) Compliance Officer SECRETARIAL AUDITORS STATUTORY AUDITORS Dipika Kataria M/s. Subhash Chand Jain Anurag & Associates, 209/A, Shehnai Residency-2, 104, Archana Apartment, Kanadia Road, 8-B, Ratlam Kothi Near Bangali Square, Indore - 452 001 Indore (M.P.) REGISTRAR AND SHARE TRANSFER AGENT M/s. Adroit Corporate Service (P) Ltd, BANKERS 19/20, Jafferbhoy, Industrial Estate, 1st Floor, Punjab National Bank, Indore Makwana Road, Marol Naka, Andheri (E), ICICI Bank, Indore Mumbai- 400 059 Mail: adroit@vsnl.net H.D.F.C Bank, Indore Ph. 022 - 28596060, 28594060, Fax - 28503748 LISTED STOCK EXCHANGES CONTENTS Page No. Bombay Stock Exchange, Mumbai Corporate Information : 01 Phiroze JeeJeebhoy Tower, Dalal Street, Notice of AGM : 03 Fort, Mumbai – 400 001. Directors’ Report : 15 Management Discussion & Analysis Report : 32 Ahmedabad Stock Exchange, Ahmedabad Corporate Governance Report : 35 Kamdhenu Complex, Shareholders Information : 41 Opp. Shahajanand College, Auditors’ Report : 47 Panjarapole, Ahmedabad - 380015 Balance Sheet : 63 Profit and Loss Account : 65 Schedules and Notes : 70 33rd Annual Report COMMITTEES OF THE BOARD Audit Committee S. Name Designation Position in the No. Committee 1. Mr. Abhinav Naik Independent Director Chairman 2. Mrs. Shreya Saraf Independent Director Member 3. Mr. Sudhir Sethi Chairman & Director Member Nomination & Remuneration Committee 1. Mr. Abhinav Naik Independent Director Chairman 2. Mrs. Shreya Saraf Independent Director Member 3. Mr. Sudhir Sethi Chairman & Director Member Stakeholders’ Relationship Committee 1. Mr. Abhinav Naik Independent Director Chairman 2. Mrs. Shreya Saraf Independent Director Member 3. Mr. Sudhir Sethi Chairman & Director Member 33rd Annual Report NOTICE 33rd ANNUAL GENERAL MEETING NOTICE is hereby given that the Thirty- Third (33rd) Annual General Meeting of Members of BERYL DRUGS LIMITED will be held on Tuesday, 29th September, 2026 at 11:00 A.M. at Kanchan Palace, Community Hall, Nipania Ring Road Indore (M.P.) to transact the following businesses: ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the Financial Year ended 31st March 2026, together with the reports of the Board of Directors and Auditors thereon, and in this regard, to consider and if thought fit, to pass, with or without modification (s) the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon laid before this meeting, be and are hereby considered and adopted.” 2. To re-appoint Mr. Sudhir Sethi (DIN: 00090172), who retires by rotation as a director and in this regard, to consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, Mr. Sudhir Sethi (DIN: 00090172), who retires by rotation at this meeting be and is hereby re-appointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS: 3. Approval for increase in the limit of material related party transactions with m/s. Aminova infusions pvt. Ltd. To consider and, if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the applicable provisions of the Companies Act, 2013 (“Act”) read with the applicable Rules made thereunder, including Section 188 and other applicable provisions of the Act, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), including Regulation 23 and other applicable provisions thereof, as amended from time to time, the Securities and Exchange Board of India circulars/guidelines applicable to Related Party Transactions, the Company's Policy on Materiality of Related Party Transactions and on dealing with Related Party Transactions, and all other applicable laws, rules, regulations, circulars and guidelines, as amended, supplemented or re- enacted from time to time, and pursuant to the approval and recommendation of the Audit Committee and the Board of Directors of the Company, consent of the Members of the Company be and is hereby accorded to revise the aggregate maximum value of the material related party transactions with M/s. Aminova Infusions Pvt Ltd. (“Aminova”) from ₹5.00 crore to ₹8.00 crore, as approved by the Members pursuant to the earlier resolution passed at the Extra Ordinary General Meeting (EOGM) held on 11th May, 2026, during the unexpired period of the existing tenure of such approval. “RESOLVED FURTHER THAT except for the aforesaid increase in the aggregate maximum monetary limit from ₹5.00 crore to ₹8.00 crore, all other terms and conditions, nature of transactions, tenure and other parameters of the earlier approval shall remain unchanged and continue to remain in force for the originally approved period of two years.” 33rd Annual Report “RESOLVED FURTHER THAT the revised aggregate maximum limit of ₹8.00 crore shall be the overall ceiling for the transactions covered under the existing approval during the originally approved two-year tenure, and the same shall not be construed as an additional ₹8.00 crore limit over and above the transactions al [Showing first 8,000 characters — download PDF for full document]